Daniel Flicker

Senior Associate

---

Daniel joined the T1D Fund in January 2025. He was previously a Senior Associate at Novo Holdings, where he focused on biotech and medtech venture investing across a wide range of company stages and therapeutic areas. He also served as a board observer for three portfolio companies.

Prior to Novo, Daniel worked in healthcare investment banking and equity research at Chardan and in life sciences-focused management consulting at L.E.K. Consulting. He received his Ph.D. in Systems Biology from Harvard University, where he completed a thesis on mitochondrial metabolism in brown adipose tissue, and his B.A. in biochemistry from Columbia University.